India to Australia: Famotidine Export Trade Route
India has recorded 28 verified shipments of Famotidine exported to Australia, representing a combined trade value of $451.2K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $16.1K USD. The leading Indian exporter is CADILA PHARMACEUTICALS LIMITED, which accounts for 63% of total export value with 11 shipments worth $284.3K USD. On the buying side, ARROW PHARMACEUTICALS PTY LTD is the largest importer in Australia with $170.5K USD in purchases. The top 3 suppliers — CADILA PHARMACEUTICALS LIMITED, CADILA PHARMACEUTICALS LIMITED , CADILA PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Famotidine corridor is one of India's established pharmaceutical export routes, with 28 shipments documented worth a combined $451.2K USD. The route is dominated by CADILA PHARMACEUTICALS LIMITED, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's famotidine manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $16.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with famotidine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 30.5%, placing it at rank #8 among India's top famotidine export destinations globally.
On the import side, key buyers of Indian famotidine in Australia include ARROW PHARMACEUTICALS PTY LTD, ARROW PHARMACEUTICALS PTY LTD., ARROW PHARMACEUTICALS PTY LTD. and 1 others. ARROW PHARMACEUTICALS PTY LTD is the single largest importer with 9 shipments valued at $170.5K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ3
- Primary modeSea freight
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#8
- Annual growth+30.5%
- Demand growth+27.3%
- Regulatory ease73/100
Top 10 Indian Famotidine Exporters to Australia
Showing top 10 of 4 Indian suppliers exporting Famotidine to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CADILA PHARMACEUTICALS LIMITED Avg $25.8K per shipment | 11 | $284.3K | 63.0% |
| 2 | CADILA PHARMACEUTICALS LIMITED Avg $9.0K per shipment | 13 | $117.6K | 26.1% |
| 3 | CADILA PHARMACEUTICALS LTD Avg $16.4K per shipment | 3 | $49.2K | 10.9% |
| 4 | TULSI MEDICAL GENERAL STORES Avg $12 per shipment | 1 | $12 | 0.0% |
This table shows the top 10 of 4 Indian companies exporting famotidine to Australia, ranked by total trade value. The listed exporters are: CADILA PHARMACEUTICALS LIMITED, CADILA PHARMACEUTICALS LIMITED , CADILA PHARMACEUTICALS LTD, TULSI MEDICAL GENERAL STORES. CADILA PHARMACEUTICALS LIMITED is the dominant supplier with 11 shipments worth $284.3K USD, giving it a 63% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Famotidine Importers in Australia
Showing top 10 of 4 known buyers in Australia receiving Famotidine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian famotidine in Australia include ARROW PHARMACEUTICALS PTY LTD, ARROW PHARMACEUTICALS PTY LTD., ARROW PHARMACEUTICALS PTY LTD. , CONSIGNEE MASTER OWNER OF SPIRIT OF MELBOURNE. The largest importer is ARROW PHARMACEUTICALS PTY LTD, accounting for $170.5K USD across 9 shipments — representing 38% of all famotidine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ARROW PHARMACEUTICALS PTY LTD | 9 | $170.5K | 37.8% |
| 2 | ARROW PHARMACEUTICALS PTY LTD. | 5 | $163.1K | 36.2% |
| 3 | ARROW PHARMACEUTICALS PTY LTD. | 13 | $117.6K | 26.1% |
| 4 | CONSIGNEE MASTER OWNER OF SPIRIT OF MELBOURNE | 1 | $12 | 0.0% |
Top 10 Famotidine Formulations Imported by Australia
Showing top 10 of 18 product formulations shipped on the India to Australia Famotidine route, ranked by trade value
Australia imports a wide range of famotidine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — AUSFAM 40MG TABLET (R/M : FAMOTIDINE PH EUR) BATCH ET262E4006 TO ET262E4010 Mfg Dt-NOV-2024 Exp Dt-OCT-2027 — accounts for $94.7K USD across 2 shipments. There are 18 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUSFAM 40MG TABLET (R/M : FAMOTIDINE PH EUR) BATCH ET262E4006 TO ET262E4010 Mfg Dt-NOV-2024 Exp Dt-OCT-2027 | 2 | $94.7K | 21.0% |
| 2 | AUSFAM 20MG TABLET (R/M : FAMOTIDINE PH EUR) BATCH ET261E5001 / ET261E5005 TO ET261E5009 Mfg Dt-JAN-2025 Exp Dt-DEC-2026 | 1 | $58.0K | 12.9% |
| 3 | AUSFAM 20MG TABLET (RM:FAMOTIDINE PH. EU | 3 | $41.7K | 9.2% |
| 4 | PHARMACEUTICAL PRODUCTS AUSFAM 20MG TABLET (RAW MATERIAL: FAMOTIDINE PH. EUR. 20MG) BATCH ET261E5002 TO ET261E5004 | 1 | $32.4K | 7.2% |
| 5 | AUSFAM 20MG TABLET R/M : FAMOTIDINE PH. EUR. 20MG BATCH ET261E3006 TO ET261E3008 MANUFACTURING : AUG/2023 EXP : JUL/2025 | 1 | $30.8K | 6.8% |
| 6 | AUSFAM 40MG TABLET (R/M : FAMOTIDINE) BA | 5 | $29.7K | 6.6% |
| 7 | AUSFAM 20MG TABLET (R/M : FAMOTIDINE PH. | 4 | $25.8K | 5.7% |
| 8 | AUSFAM 40MG TABLET (RAW MATERIAL : FAMOTIDINE) BATCH ET262E4001, ET262E4002 & ET262E4003 (AS PER INV) | 1 | $25.4K | 5.6% |
| 9 | PHARMACEUTICAL PRODUCTS AUSFAM 40MG TABLET (RAW MATERIAL : FAMOTIDINE) BATCH ET262E4004 & ET262E4005 (ASPERINV) | 1 | $21.6K | 4.8% |
| 10 | PHARMACEUTICAL PRODUCTS AUSFAM 20MG TABLET (RAW MATERIAL: FAMOTIDINE PH. EUR. 20MG) BATCH ET261E4001 & ET261E4002 | 1 | $20.7K | 4.6% |
Showing top 10 of 18 Famotidine formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 17 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's famotidine exports to Australia are driven primarily by a handful of large-scale manufacturers. CADILA PHARMACEUTICALS LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CADILA PHARMACEUTICALS LIMITED, CADILA PHARMACEUTICALS LIMITED , CADILA PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $16.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ausfam 20mg tablet (r/m : famotidine ph eur) batch et261e5001 / et261e5005 to et261e5009 mfg dt-jan-2025 exp dt-dec-2026 and ausfam 20mg tablet (rm:famotidine ph. eu , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ARROW PHARMACEUTICALS PTY LTD is the largest importer with 9 shipments worth $170.5K USD — representing 38% of all famotidine imports from India on this route.
Route Statistics
- Trade Volume
- $451.2K
- Avg. Shipment
- $16.1K
- Suppliers
- 4
- Buyers
- 4
- Transit (Sea)
- ~16 days
- Annual Growth
- +30.5%
Related Analysis
Other Famotidine Routes
Unlock the Full India to Australia Famotidine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 28 shipments on this route.
Frequently Asked Questions — India to Australia Famotidine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Famotidine to Australia?
The leading Indian exporters of Famotidine to Australia are CADILA PHARMACEUTICALS LIMITED, CADILA PHARMACEUTICALS LIMITED , CADILA PHARMACEUTICALS LTD. CADILA PHARMACEUTICALS LIMITED holds the largest market share at approximately 63% of total trade value on this route.
Q What is the total value of Famotidine exports from India to Australia?
India exports Famotidine to Australia worth approximately $451.2K USD across 28 recorded shipments. The average value per shipment is $16.1K USD.
Q Which ports does India use to ship Famotidine to Australia?
The most active port of origin is MUNDRA SEA (INMUN1) with 17 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Australia for Famotidine?
The average transit time for Famotidine shipments from India to Australia is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Australia Famotidine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.5% with demand growth tracking at 27.3%. The route is ranked #8 among India's top Famotidine export destinations globally.
Q How many suppliers are active on the India to Australia Famotidine route?
There are currently 4 active Indian suppliers exporting Famotidine to Australia. The market is moderately concentrated with CADILA PHARMACEUTICALS LIMITED accounting for 63% of total shipment value.
Q Who are the main importers of Famotidine from India in Australia?
The leading importers of Indian Famotidine in Australia include ARROW PHARMACEUTICALS PTY LTD, ARROW PHARMACEUTICALS PTY LTD., ARROW PHARMACEUTICALS PTY LTD. , CONSIGNEE MASTER OWNER OF SPIRIT OF MELBOURNE. ARROW PHARMACEUTICALS PTY LTD is the largest buyer with 9 shipments worth $170.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Famotidine.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 4 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 28 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
28 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists